Sluiten
Biologics safety profile
Episode 6 - Podcast Serie 2026 - Prof. Tom Hillary and Prof. Reinhart Speeckaert (NL)
In this episode we dive into a subject that is becoming increasingly central in modern dermatological practice: the safety profile of biologics. These drugs have profoundly changed the treatment of inflammatory skin conditions such as psoriasis and atopic dermatitis in recent years. However, as use increases, questions — about long-term safety, specific side effects, vulnerable patient groups and proper monitoring also grow.